Skip to content

Research on the specific effects and the key influential factors of acupoints: research based on the treatment of brain-resusciatating acupuncture for cerebral infarction

Research on the specific effects and the key influential factors of acupoints

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-07000036
Enrollment
Unknown
Registered
2007-11-04
Start date
2007-05-26
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

The acute phase of cerebral infarction

Interventions

Control group:Non-acupoints needling
Brain-resusciatating accupuncture group:Brain-resusciatating accupuncture

Sponsors

The First Affiliated Hospital of Tianjin University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Patients with the diagnosis of basal ganglion infarction, and free of intracranial hemorrhage confirmed by CT or MRI; 2. First onset; 3. Aged between 40 and 75 years old; 4. Criteria of pathological stages: within the acute stage and 2 weeks after the onset; 5. Vital signs remain stable after the onset; 6. CSS score >7; and the muscle strength of the upper and lower limbs of the affected side <IV.

Exclusion criteria

Exclusion criteria: 1. Severe conscious disorder; 2. History of atrial fibrillation or combined with severe primary cardiovascular, hepatic, renal and hematological diseases; 3. Severe complications, such as heart failure, renal failure and cancer; 4. Patients with history of psychotic disorder or dementia, and cognitive impairment or sensory aphasia, that cannot express themselves; 5. Patients with disorder of limb's activity caused by rheumatoid, amputation and congenital disability, et al; 6. Patients who cannot complete the basic treatment course and patients with low compliance; 7. The muscle strength of the upper and lower limbs of the affected side >=IV; 8. Patients with unstable mood, sleep dysfunction, fluctuation of BP and constipation.

Design outcomes

Primary

MeasureTime frame
Neurologic function impairment;Mortality;Quality of Life;Daily living capacity;

Countries

China

Contacts

Public ContactXuemin Shi
tjdrshi@msn.com+86 022 13902026660

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026